Short answer
Kimberly-Clark (KMB) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item EX-99.3 (Exhibit EX-99.3), Item EX-99.4 (Exhibit EX-99.4). Exchange offer targets all outstanding Kenvue Notes for up to $7.0 billion of new Kimberly-Clark notes plus cash.
Kimberly-Clark 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Exchange offer targets all outstanding Kenvue Notes for up to $7.0 billion of new Kimberly-Clark notes plus cash
- Consent solicitations would remove most Kenvue debt covenants, selected default triggers, SEC reporting requirements, and merger restrictions
- Offers conditioned on First Merger completion, expected in fourth-quarter 2026
- Pro forma financials and Kenvue audited and interim statements provide investor visibility into the combined company’s potential profile
- Pro forma results are informational and not predictive of post-merger financial performance
Item EX-99.1 · Exhibit EX-99.1
- Exchange offers cover up to $7.0 billion of Kenvue notes, contingent on completing the acquisition in fourth quarter 2026
- Early tenders receive $970 Kimberly-Clark notes, $30 premium and $1 cash per $1,000 Kenvue notes
- Kimberly-Clark assumes unsecured senior debt with matching rates, maturities, payment dates and redemption terms
- Consent solicitations would remove most Kenvue noteholder protections, including restrictive covenants and certain default triggers
- Early participation deadline October 9, 2026; offers expire October 27, 2026; withdrawal deadline October 9, 2026
Item EX-99.2 · Exhibit EX-99.2
- Audited Kenvue financials cover fiscal years through December 28, 2025, with PwC issuing an unqualified opinion
- FY2025 net sales $15.124B, down from $15.455B, while net income rose to $1.470B from $1.030B
- Operating income $2.414B, helped by lower impairment charges, despite $290M restructuring expense
- Operating cash flow $2.197B supported $1.581B dividends, $475M capital spending and $197M share repurchases
- Kimberly-Clark merger advanced: shareholder approvals obtained, antitrust waiting period expired, foreign regulatory approvals remain outstanding
Item EX-99.3 · Exhibit EX-99.3
- Kenvue Q2 net sales $3,955M, up from $3,839M, supporting the pending Kimberly-Clark combination with modest topline growth
- Six-month operating income $1,466M versus $1,250M, while net income rose to $930M from $742M
- Operating cash flow reached $1,177M, funding $796M of dividends and $245M of capital spending
- Pending merger consideration: 0.14625 Kimberly-Clark shares plus $3.50 cash per Kenvue share
- Regulatory risk remains: shareholder approvals and U.S. antitrust clearance completed, but foreign approvals still required
Item EX-99.4 · Exhibit EX-99.4
- Pro forma merger combines K-C and Kenvue, with K-C holders owning approximately 54% and Kenvue holders approximately 46%
- Expected fourth-quarter 2026 closing remains subject to regulatory approvals and customary conditions
- Pro forma 2025 sales $31.483B and net income attributable to K-C $2.109B
- Financing includes expected $4.9B permanent debt, with pro forma long-term debt reaching $18.223B
- Preliminary purchase accounting adds $22.994B of intangible assets and $4.061B of goodwill, creating valuation and future amortization risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Kimberly-Clark 8-K filings
Get the next KMB 8-K as it lands
Follow KMB for push alerts, or ask the research agent what this filing means.